NCT04912050View on ClinicalTrials.gov

EXtension of Tablo TrEatmeNt Duration Registry

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

May 25, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
End Stage Renal Disease (ESRD)End Stage Renal Disease on DialysisAcute Kidney Injury
Interventions
DEVICE

Tablo Hemodialysis System

Renal Replacement Therapy between 12\< to ≤ 24 hours.

Trial Locations (1)

84124

St. Mark's Hospital, Salt Lake City

Sponsors

Lead Sponsor

Outset Medical
All Listed Sponsors
lead

Outset Medical

INDUSTRY